Meeting of Personalised Medicine All Party Parliamentary Group
House of Lords, London, 28 Feb 2017
Dr Robert Rintoul, lead clinician for thoracic oncology at Papworth Hospital and Owlstone Medical Scientific Advisor joined a meeting of the Personalised Medicine All Party Parliamentary Group at the House of Lords. At the meeting he discussed with the group his ongoing work with Owlstone Medical to develop a breath test for early stage lung cancer.
Dr Robert Rintoul explains the value of @sbrihealthcare @OwlstoneNano breath analyser for screening @personalised meds all party group pic.twitter.com/BHvMklgRnm
— Karen Livingstone (@LivingstoneSBRI) February 28, 2017
Dr Robert Rintoul @PapworthHosp outlines research with @OwlstoneNano breath test for early stage lung cancer to @personmedAPPG pic.twitter.com/WbVdZDmei2
— Philippa Brice (@PhilippaBrice) 28 February 2017
Dr Robert Rintoul @PapworthHosp tells @personmedAPPG that earlier detection of lung cancers is vital to improve patient outcomes pic.twitter.com/4moQOxTHMG
— Philippa Brice (@PhilippaBrice) 28 February 2017
Now hearing from Dr Robert Rintoul @PapworthHosp on earlier, non-invasive diagnosis for #lungcancer #personalisedmed pic.twitter.com/UmAcY3ihvq
— PersonMed APPG (@personmedAPPG) 28 February 2017
